Tenet Healthcare (THC)
(Delayed Data from NYSE)
$151.63 USD
+1.89 (1.26%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $151.64 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$151.63 USD
+1.89 (1.26%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $151.64 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth A Momentum A VGM
Zacks News
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Universal Health Services, Inc. (UHS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
by Zacks Equity Research
Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet (THC) Q2 Earnings Beat on Patient Volumes, '24 EPS View Up
by Zacks Equity Research
Tenet Healthcare's (THC) Q2 results reflect net revenue per case growth, higher pricing yield and a decline in overall expenses. It expects 2024 adjusted EPS within $10.41-$11.12, up from the previous guidance of $8.37-$9.41.
Tenet (THC) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Tenet Healthcare (THC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 22.22% and 2.49%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Play Likely Earnings Beat With 5 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks The Wingstop (WING), Amazon.com (AMZN), Burlington Stores (BURL), Tenet Healthcare (THC) and Twilio (TWLO) are likely to beat on the bottom line in their upcoming releases.
Tenet (THC) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Tenet (THC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for July 23rd
by Zacks Equity Research
WGS, THC and APOG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 23, 2024.
Can These 3 Hospital Stocks Beat Q2 Earnings Expectations?
by Kaibalya Pravo Dey
Rising patient volumes, admission and occupancy levels are expected to have benefited hospital players in the second quarter, partly offset by higher costs. THC, UHS and CYH will release earnings on Jul 24.
Here's How STERIS (STE) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.
Zacks.com featured highlights include Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy
by Zacks Equity Research
Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy are part of the Zacks Screen of the Week article.
New Strong Buy Stocks for July 23rd
by Zacks Equity Research
KRO, TEF, STX, WGS and THC have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 2024.
Best Value Stocks to Buy for July 23rd
by Zacks Equity Research
KBH, APOG and THC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2024.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Stocks With Impressive Interest Coverage Ratio to Buy Now
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. AMZN, HALO, THC and ATO are sound enough to meet financial obligations.
Tenet Healthcare (THC) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $133.27, moving +1.15% from the previous trading session.
Buying Tenet (THC) Pre-Q2 Earnings: A Prescription for Profits?
by Kaibalya Pravo Dey
Tenet Healthcare's (THC) second-quarter earnings are likely to have benefited from higher admissions, average length of stay and patient days.
4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
by Zacks Equity Research
Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.
Tenet Healthcare (THC) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the latest trading session, Tenet Healthcare (THC) closed at $131.75, marking a -1.26% move from the previous day.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
by Zacks Equity Research
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Tenet Healthcare (THC) Gained But Lagged the Market Today
by Zacks Equity Research
Tenet Healthcare (THC) closed at $134.39 in the latest trading session, marking a +0.49% move from the prior day.